Insider Transactions in Q2 2024 at Relay Therapeutics, Inc. (RLAY)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2024
|
Peter Rahmer |
BUY
Grant, award, or other acquisition
|
Direct |
2,108
+0.48%
|
$10,540
$5.54 P/Share
|
|
Jun 30
2024
|
Sanjiv Patel President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,108
+0.27%
|
$10,540
$5.54 P/Share
|
|
Jun 27
2024
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,373
-1.38%
|
$56,238
$6.25 P/Share
|
|
Jun 27
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
245
-0.06%
|
$1,470
$6.26 P/Share
|
|
Jun 27
2024
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
648
-0.12%
|
$3,888
$6.26 P/Share
|
|
Jun 27
2024
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
295
-0.09%
|
$1,770
$6.26 P/Share
|
|
Jun 10
2024
|
Jami Rubin |
BUY
Exercise of conversion of derivative security
|
Direct |
42,242
+38.58%
|
$211,210
$5.04 P/Share
|
|
Jun 05
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
20,450
-4.52%
|
$143,150
$7.06 P/Share
|
|
Jun 04
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
40,595
-8.23%
|
$243,570
$6.64 P/Share
|
|
Jun 03
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
19,864
-3.87%
|
$119,184
$6.47 P/Share
|
|
Apr 29
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
1,345
-0.26%
|
$8,070
$6.38 P/Share
|
|
Apr 29
2024
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
2,686
-0.51%
|
$16,116
$6.38 P/Share
|
|
Apr 29
2024
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,695
-0.5%
|
$10,170
$6.38 P/Share
|
|
Apr 29
2024
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,623
-0.5%
|
$9,738
$6.38 P/Share
|